+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin and NSAID use and prostate cancer risk



Statin and NSAID use and prostate cancer risk



Pharmacoepidemiology and Drug Safety 19(7): 752-755



Some studies have reported reduced risks of advanced, but not early, prostate cancer among statin users, and one study found a reduced risk only among statin users who had also used non-steroidal anti-inflammatory drugs (NSAIDs). We have previously reported no association between statin use and prostate cancer in our hospital-based Case Control Surveillance Study. The purpose of the present analyses was to update the findings by cancer stage and to evaluate the joint use of statins and NSAIDs. Cases were 1367 men with prostate cancer and controls were 2007 men with diagnoses unrelated to statin or NSAID use. We used multivariable logistic regression analyses to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for statin use compared with no use, and joint use of statin and NSAIDs compared with use of neither. The odds ratio among regular statin users was 1.1 (95%CI 0.9-1.5), and odds ratios were similar among early and late stage cancers. The odds ratio among joint statin and NSAID users was 1.1 (95%CI 0.7-1.6). The present results do not support a protective effect of statin use, or statin and NSAID use, on the risk of advanced prostate cancer.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911040

Download citation: RISBibTeXText

PMID: 20582910

DOI: 10.1002/pds.1970


Related references

Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use. Cancer 117(8): 1640-1648, 2011

Statin use and the risk of breast and prostate cancer. Epidemiology 13(3): 262-267, 2002

Statin Use and Risk of Prostate Cancer in MrOS. 2012

Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men. Cancer Genetics 206(7-8): 266-278, 2013

Statin drugs and risk of advanced prostate cancer. Journal of the National Cancer Institute 98(24): 1819-1825, 2006

Statin use and the risk of prostate-specific antigen recurrence after radiation therapy with or without hormone therapy for prostate cancer. Journal of Clinical Oncology 28(16): 2651-2652, 2010

Re: Statin drugs and risk of advanced prostate cancer (PC) - Platz. 2007

Statin drug use is not associated with prostate cancer risk in men who are regularly screened. Journal of Urology 192(2): 379-384, 2014

Statin use and risk of prostate cancer in a population of men who underwent biopsy. Journal of Urology 186(1): 86-90, 2011

The risk of prostate cancer for men on aspirin, statin or antidiabetic medications. European Journal of Cancer 51(6): 725-733, 2015

Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior. Arthritis and Rheumatism 57(8): 1539-1545, 2007

Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. Journal of Clinical Oncology 28(16): 2653-2659, 2010

Statin use and risk of prostate cancer: a meta-analysis of observational studies. Plos One 7(10): E46691-E46691, 2013

Words of wisdom. Re: Statin drugs and risk of advanced prostate cancer (PC). European Urology 52(4): 1258-1259, 2007

Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiology, Biomarkers & Prevention 16(11): 2218-2225, 2007